Scarica l'app Stockscreener
8.96
9.40%
0.77
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$8.19
Aprire:
$8.69
Volume 24 ore:
2.40M
Relative Volume:
2.83
Capitalizzazione di mercato:
$316.41M
Reddito:
$2.07M
Utile/perdita netta:
$-47.68M
Rapporto P/E:
-3.1773
EPS:
-2.82
Flusso di cassa netto:
$-31.31M
1 W Prestazione:
+0.34%
1M Prestazione:
-21.30%
6M Prestazione:
-48.03%
1 anno Prestazione:
-9.04%
Intervallo 1D:
$8.68
$9.28
Intervallo di 1 settimana:
$8.12
$9.28
Portata 52W:
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Nome
Delcath Systems Inc
Settore
Industria
Telefono
(518) 743-8892
Indirizzo
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Confronta DCTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
8.96 | 289.22M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-28 | Iniziato | Craig Hallum | Buy |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2022-07-26 | Ripresa | Canaccord Genuity | Buy |
| 2021-12-10 | Iniziato | H.C. Wainwright | Buy |
| 2021-03-09 | Iniziato | Canaccord Genuity | Buy |
| 2021-01-05 | Iniziato | BTIG Research | Buy |
| 2020-06-01 | Iniziato | Laidlaw | Buy |
Mostra tutto
Delcath Systems Inc Borsa (DCTH) Ultime notizie
Delcath Systems (NASDAQ:DCTH) Board Authorizes Stock Repurchase Plan - MarketBeat
Responsive Playbooks and the DCTH Inflection - news.stocktradersdaily.com
Delcath Systems authorizes $25 million share repurchase program - MSN
Why We're Not Concerned Yet About Delcath Systems, Inc.'s (NASDAQ:DCTH) 28% Share Price Plunge - simplywall.st
Delcath Systems authorizes $25 million share repurchase program By Investing.com - Investing.com Canada
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program - BioSpace
How supply shortages influence Delcath Systems Inc. (DV3R) stockEarnings Growth Summary & Entry and Exit Point Strategies - newser.com
Biotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound - Nasdaq
Delcath Systems board authorizes $25 million share repurchase program By Investing.com - Investing.com Nigeria
Delcath Systems board authorizes $25 million share repurchase program - Investing.com India
Delcath Systems (DCTH) Initiates $25 Million Share Buyback Progr - GuruFocus
Delcath Systems Announces $25M Share Buyback Plan - TipRanks
[8-K] DELCATH SYSTEMS, INC. Reports Material Event | DCTH SEC FilingForm 8-K - Stock Titan
Delcath Systems, Inc. announces an Equity Buyback for $25 million worth of its shares. - MarketScreener
Delcath Systems board of directors authorizes $25 million share repurchase program - MarketScreener
Domino's Pizza (Nasdaq: DPZ) brings back $9.99 any-topping pizzas promotion - Stock Titan
Can Delcath Systems Inc. (DV3R) stock beat analyst consensusWeekly Trade Analysis & Consistent Profit Trade Alerts - newser.com
Can Delcath Systems Inc. (DV3R) stock attract ESG investmentsWeekly Loss Report & Technical Analysis for Trade Confirmation - newser.com
What analyst consensus says on Delcath Systems Inc. stockBear Alert & Verified Trade Idea Suggestions - newser.com
Forecasting Delcath Systems Inc. price range with options dataJuly 2025 Momentum & Risk Managed Investment Entry Signals - newser.com
How Delcath Systems Inc. (DV3R) stock reacts to Fed tighteningDollar Strength & Free Reliable Trade Execution Plans - newser.com
Delcath Systems Shares Tick Higher After Study Highlights Strong Outcomes for Liver Cancer Treatment - MSN
Will Delcath Systems Inc. stock reach all time highs in 2025Market Performance Recap & AI Driven Stock Price Forecasts - newser.com
Real time breakdown of Delcath Systems Inc. stock performanceJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Why Delcath Systems Inc. (DV3R) stock trades below fair value2025 Valuation Update & Weekly High Return Opportunities - newser.com
Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma - BioSpace
Is Delcath Systems Inc. showing signs of accumulation - newser.com
Will Delcath Systems Inc. benefit from macro trends2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Will Delcath Systems Inc. (DV3R) stock issue positive guidanceMarket Sentiment Review & Risk Adjusted Buy/Sell Alerts - newser.com
Volatility clustering patterns for Delcath Systems Inc.Breakout Watch & Free Growth Oriented Trading Recommendations - newser.com
Delcath Systems, Inc. authorizes a Buyback Plan. - MarketScreener
Delcath Systems (DCTH) Highlights Promising Results for Liver Me - GuruFocus
H.C. Wainwright Reiterates a Buy on Delcath Systems (DCTH), Lowers the PT - Insider Monkey
10 Fast-Growing Small Cap Stocks to Buy According to Analysts - Insider Monkey
Delcath Systems Reports Positive CHOPIN Trial Results - MSN
Delcath Systems Inc Azioni (DCTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):